Skip Navigation

Radiation and Nuclear Countermeasures Program

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Expired Opportunities

Grants

Requests for Information (RFIs)

Request for Information (Department of the Army – Solicitation #W911QY-13-S-0003): Identification of Radiological Diagnostic Devices. Due Date: March 26, 2013.

DARPA-SN-13-24: Reducing Ionizing Radiation Risk (RFI). Receipt date April 2, 2013.

Request for Information: Joint Program Executive Office for Chemical and Biological Defense (CBMS-MITS), Department of Defense: Identification of a Physical Dosimetry or Biodosimeter as a Medical Radiation Countermeasure (MRADC) (responses due Jan. 28, 2012).

Mechanisms, Detection and Countermeasure Research and Development for Mixed-Field Radiation Exposure (responses due February 3, 2012)

NOT-AI-11-044 - Request for Information (RFI): Pediatric and Geriatric Animal Models and Medical Countermeasures Development for Mitigation and Treatment of Radiation Exposure from a Radiological or Nuclear Incident (response date July 19, 2011)

RFI-BARDA-08-21A: Physical and Biological Dosimetry Techniques and Devices Useful in Initial Triage After Radiologic and Nuclear Events. Issued by ASPR, OS, DHHS on May 20, 2008.

NOT-AI-07-033: Agents to Enhance Platelet Regeneration and Increase Survival following Radiation Exposure (Issued May 24, 2007).

NOT-AI-07-028: GLP Radionuclide Testing Facilities (Issued March 23, 2007).

Centers for Medical Countermeasures Against Radiation—Request for Information (Released April 9, 2004).

Neutropenia RFI Issued by HHS (Released October 29, 2004).

Requests for Applications (RFAs)

RFA-AI-12-023: Development of Medical Countermeasures for Post-Exposure Mitigation/Treatment of Injuries Resulting from a Radiation/Nuclear Incident (U01)

RFA-AI-11-033: Predictive Biodosimetry: Discovery and Development of Biomarkers for Acute and Delayed Radiation Injuries (R01)

RFA-09-036: Centers for Medical Countermeasures Against Radiation (U19)

RFA-DK-08-010: Intestinal Stem Cell Consortium (U01) - Co-Funded by the NIAID Radiation/Nuclear Program. Receipt date: March 18, 2009.

NSBRI-RFA-08-02: Research Opportunities Soliciting an NSBRI Center of Acute Radiation Research for Ground-Based Studies on Acute Radiation Effects (Due date: May 8, 2008).

RFA-AI-07-040, BARDA/NIAID Medical Countermeasures to Mitigate and/or Treat Ionizing Radiation-Induced Pulmonary Injury: Project Bioshield (RC1) (Due date: March 11, 2008).

RFA-AI-07-037: BARDA/NIAID Medical Countermeasures to Mitigate and/or Treat Ionizing Radiation-Induced Cutaneous Injury: Project Bioshield (RC1) (Due date: March 11, 2008).

RFA-AI-07-038: Radiation Combined Injury: Radiation Exposure in Combination with Burn, Wound, Trauma, or Infection (Phased Innovation Award [R21/R33]) (Due date: January 24, 2008

RFA-AI-07-039: Mechanisms, Diagnosis, and Treatment of Radiation Injury from a Nuclear Accident or Terrorist Attack (R01) (Due date: January 15, 2008).

RFA-AI-07-036: Medical Countermeasures to Enhance Platelet Regeneration and Increase Survival Following Radiation Exposure (RC1) (Due date: January 9, 2008).

RFA-AI-07-013: Medical Countermeasures to Restore Gastrointestinal Function after Radiation Exposure: Project Bioshield (RC1) (Due date: April 19, 2007).

NASA Research Announcement (NRA) for Ground-Based Studies in Radiation Biology Solicitation No. NNJ07ZSA001N—External link (Issued January 5, 2007).

Announcement: Biodefense Countermeasure Development: Project Bioshield: Protecting the Immune System Against Radiation (Released July 23, 2004).

Centers for Medical Countermeasures against Radiation—RFA-AI-04-045 (Released November 23, 2004).

Radionuclide Decorporation Agents for Radiation/Nuclear Emergencies: Project BioShield (R01)—RFA-AI-06-030 (Released March 30, 2006).

Program Announcements

PA-09-093: Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR[R43/R44])

Public Briefings

CMCR Public Briefing (December 15, 2004).

Contracts

BAA-NIAID-DAIT-NIHAI2013166 - Development of Medical Countermeasures to Enhance Platelet Regeneration and Survival Following Radiation Exposure from a Radiological/Nuclear Incident. Due Date July 1, 2013

FDA BAA-12-00118: Food and Drug Administration Broad Agency Announcement for the Advanced Research and Development of Regulatory Science and Innovation. Continuously open announcement valid through May 22, 2013.

BARDA-CBRN-BAA-12-100-SOL-00011: Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medicine Countermeasures

Department of Defense: CHEMICAL AND BIOLOGICAL DEFENSE PROGRAM SBIR 13.1 Proposal Submission – Topic CBD13-108: Rapid biodosimetry for accurate assessment of individual radiation exposure levels (Due Date – January 16, 2013).

BARDA-BAA-11-100-SOL-009: Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures)

PHS 2011-1: Solicitation of NIH and CDC for Small Business Innovation Research (SBIR) Contract Proposals. Research topics identified include: NCI Topic 291 - Radioprotector/Mitigator Development to Decrease Normal Tissue Injury During Radiotherapy. Due Date: November 8, 2010. Download Solicitation Package (PDF).

RFP-NIAID-DAIT-NIHAI2009079: Radiation/Nuclear Medical Countermeasure Product Development Support Services

BAA-NIAID-DAIT-NIHAI2009051: Development of Oral Radionuclide Decorporation Agents for Use in Radionuclide Decorporation in Radiological Emergencies

BAA-NIAID-DAIT-NIHAI2009060: Development of Oral Form of Diethylenetriaminepentaacetate (DTPA) for Use in Radionuclide Decorporation – Radiological Emergency

Issued by the Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (BAA-BARDA-09-36): Point of Care of High-Throughput Biological Assays for Determining Absorbed Ionizing Radiation Dose (Biodosimetry) after Radiologic and Nuclear Events.

Issued by the Defense Threat Reduction Agency (DTRA): BAA for Chemical and Biological Technologies Directorate New Initiatives FY2010-FY2011, October 17, 2008. See BAA Amendment 1, October 30, 2008 for Radiation Topics.

Issued by the U.S. Special Operations Command, June 26, 2007: Broad Agency Announcement, Bio-Medical Research Topics.

Defense Threat Reduction Agency’s (DTRA's) Basic Research Program for Combating Weapons of Mass Destruction (WMD) and Basic Research in the Chemical Biological Defense Program. (HDTRA1-07-BRCWMD-BAA. Phase I proposal receipt deadline: June 8, 2007.)

RFP Issued by the U.S. Army Space and Missile Defense Command: Solicitation # W9113M-07-R-0002: To Develop and Deliver in Minimal Time and Minimal Cost, an FDA-Approved Medical Countermeasure for Radiation Injury to Increase Survival following Radiation Exposure (Issued February 16, 2007).

RFP-NIH-NIAID-DAIT-05-46, Development of Improved DTPA for Radionuclide Chelation (Released May 6, 2005).

Draft RFP Issued by the Office of Public Health Emergency Preparedness (HHS): Medical Countermeasures to Mitigate or Treat Neutropenia Associated with Acute Radiation Syndrome (ARS) That Will Support a Public Health Emergency Response to a Radiological or Nuclear Event (RFI-ORDC-05-01A).

Issued April 10, 2007, by the Defense Advanced Research Projects Agency (DARPA): BAA 07-29: Radiation Biodosimetry (RaBid) Announcement.

Issued by the Department of Health and Human Services, May 30, 2007: Therapeutics Applicable for the Treatment of Neutropenia Resulting from Exposure to Ionizing Radiation

Issued by the Department of Defense, CBMS-MITS (Solicitation # W9113M-09-R-0010): Advanced Development of a Medical Radiation Countermeasure (MRC) to treat the Gastrointestinal Subsyndrome of Acute Radiation Syndrome (ARS)

BAA-NIAID-DAIT-NIHAI2012147: Development of Medical Countermeasures to Mitigate or Treat the Gastrointestinal Acute Radiation Syndrome after a Nuclear or Radiation Incident (responses due November 15, 2012)

back to top

Last Updated July 24, 2013

Last Reviewed June 19, 2012